Pharmabiz

NAB-CCM to initiate structured awareness programmes for stakeholders on GSDP

NAB-CCM to initiate structured awareness programmes for stakeholders on GSDP: Shardul Nautiyal, Mumbai Wednesday, July 8, 2026, 08:00 Hrs [IST] The National Accreditation Body for ...
Pharmabiz

Incyte completes acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics

Incyte completes acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics: Wilmington, Delaware Wednesday, July 8, 2026, 13:00 Hrs [IST] Incyte, a biopharm ...
Pharmabiz

J P Nadda reviews implementation of key health programmes in Kerala with state health minister K Muraleedharan

J P Nadda reviews implementation of key health programmes in Kerala with state health minister K Muraleedharan: Our Bureau, Mumbai Wednesday, July 8, 2026, 11:30 Hrs [IST] Union m ...
Pharmabiz

Roche to present new data from its Alzheimer’s disease portfolio at AAIC 2026 in London on 12-15 July

Roche to present new data from its Alzheimer’s disease portfolio at AAIC 2026 in London on 12-15 July: Basel Wednesday, July 8, 2026, 12:00 Hrs [IST] Roche announced that it wil ...
Pharmabiz

J P Nadda chairs high level meeting to strengthen support for TB Mukt Bharat Abhiyaan

J P Nadda chairs high level meeting to strengthen support for TB Mukt Bharat Abhiyaan: Our Bureau, Mumbai Wednesday, July 8, 2026, 11:15 Hrs [IST] Union minister of health and fam ...
Pharmabiz

Digital health platforms are transforming pregnancy monitoring in India: Kiran Meena

Digital health platforms are transforming pregnancy monitoring in India: Kiran Meena: Our Bureau, Mumbai Wednesday, July 8, 2026, 11:45 Hrs [IST] Prenatal screening powered by art ...
Pharmabiz

Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay

Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay: Brea, California Wednesday, July 8, 2026, 11:00 Hrs [IST] Beckman Coulter Diagnostics, a glo ...
Pharmabiz

EnteroBiotix begins patient dosing in phase 2b RISE study of EBX-102-02 in irritable bowel syndrome with constipation

EnteroBiotix begins patient dosing in phase 2b RISE study of EBX-102-02 in irritable bowel syndrome with constipation: Glasgow, Scotland Wednesday, July 8, 2026, 10:00 Hrs [IST] E ...
Pharmabiz

UK MHRA approves Incyte Biosciences’ retifanlimab to treat advanced Merkel cell skin cancer

UK MHRA approves Incyte Biosciences’ retifanlimab to treat advanced Merkel cell skin cancer: United Kingdom Wednesday, July 8, 2026, 09:00 Hrs [IST] The Medicines and Healthcare ...
Pharmabiz

One health approach to contain antimicrobial resistance

The two articles from the prestigious Lancet, ‘Buden of antimicrobial resistance (AMR) in India: a systematic analysis of Global Burden of Disease Study 2019’ and ‘Preprocedural screening of multidrug ...
Pharmabiz

DoP calls for proposals for SMDI sub-scheme to set up common facilities for medical devices clusters

DoP calls for proposals for SMDI sub-scheme to set up common facilities for medical devices clusters: Gireesh Babu, New Delhi Wednesday, July 8, 2026, 08:00 Hrs [IST] The Departme ...
Pharmabiz

Talent, risk-taking & partnerships will power Indian pharma’s future: Glen Saldhana

Talent, risk-taking & partnerships will power Indian pharma’s future: Glen Saldhana: Nandita Vijayasimha, Bengaluru Wednesday, July 8, 2026, 08:00 Hrs [IST] Investing in talent, ...